BBA
PRTK

Baader Bank Aktiengesellschaft’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,580
Closed -$22.9K – 514
2023
Q1 		$22.9K Buy
+11,580
New +$22.9K ﹤0.01% 340

Other funds holding PRTK

NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Baader Bank Aktiengesellschaft's PRTK Position: Q2 2023 in Review

Baader Bank Aktiengesellschaft sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2023, closing a stake of 11,580 shares — an estimated $22.9K sold.

Baader Bank Aktiengesellschaft first reported a position in PRTK in Q1 2023 and held it in 1 quarter. The position peaked at $22.9K in Q1 2023. 66 funds tracked by Wall St. Rank hold PRTK as of Q2 2023.

  • Baader Bank Aktiengesellschaft reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 11,580 Paratek Pharmaceuticals, Inc. shares in Q2 2023, an estimated $22.9K.
  • Baader Bank Aktiengesellschaft first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2023 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's Paratek Pharmaceuticals, Inc. position peaked at $22.9K in Q1 2023.
  • 66 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2023.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2023, filed 11 Aug 2023.